Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney DiseaseDick de Zeeuw, Glenn M. Chertow, Paul Audhya et al.|New England Journal of Medicine|2013Cited by 990
The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores Nrf2 activity and attenuates oxidative stress, inflammation, and fibrosis in rats with chronic kidney diseaseMohammad A. Aminzadeh, Colin J. Meyer|Xenobiotica|2013Cited by 78